Results 11 to 20 of about 19,509 (202)
Pharmacogenetic polymorphisms affecting bisoprolol response. [PDF]
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021 β-blockers are commonly prescribed to treat multiple cardiovascular (CV) diseases, but, frequently, adverse drug reactions and intolerance limit their use in clinical practice.
C. Castaño-Amores +8 more
semanticscholar +2 more sources
Beta blockers for the treatment of arrhythmias: Bisoprolol - a systematic review.
Annales Pharmaceutiques Françaises, 2022 OBJECTIVES Beta blockers have long been successfully used for the treatment of both supraventricular and ventricular arrhythmias. However, differences exist between their chemical structure, pharmacokinetic and pharmacodynamic properties (absorption ...
L. Mureşan +7 more
semanticscholar +2 more sources
Bisoprolol in the treatment of chronic heart failure
Vascular Health and Risk Management, 2007 Pascal de Groote1, Pierre-Vladimir Ennezat2, Fréderic Mouquet11Service de Cardiologie C, 2Service des soins intensifs cardiologiques, Hôpital Cardiologique, Centre Hospitalier Régional et Universitaire de Lille, FranceAbstract ...
Pascal de Groote +2 more
doaj +1 more source
BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
Рациональная фармакотерапия в кардиологии, 2015 Aim. To compare efficacy of bisoprolol and bisoprolol+metformin combination in patients with arterial hypertension (AH) and metabolic syndrome (MS).Material and methods. 20 patients with AH and MS were involved in the study.
V. A. Nevzorova +3 more
doaj +5 more sources
THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE
Рациональная фармакотерапия в кардиологии, 2016 Data of the evidence based medicine about bisoprolol treatment of patients with cardiovascular diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders) are presented.
Yu. V. Lukina, S. Yu. Martsevich
doaj +3 more sources
Reviews in Analytical Chemistry, 2021 Two new potentiometric sensors were created for the quantification of bisoprolol fumarate and alverine citrate in bulk pharmaceutical dosage forms and human serum.
Elgendy Khaled +4 more
doaj +2 more sources
Monitoring Serum Bisoprolol Concentrations in Patients With Heart Failure With Reduced Ejection Fraction: Results of a Pilot Study From Routine Health Care [PDF]
Pharmacology Research & PerspectivesBisoprolol is a second‐generation, highly selective beta‐1 adrenergic receptor antagonist with various beneficial effects in patients with heart failure.
Ivana Kacirova +5 more
doaj +2 more sources
Clinical and Experimental Hypertension, 2020 β blockers (BBs) play an important role in heart failure (HF) treatment. However, orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch works more slowly and is long acting compared with the bisoprolol fumarate tablet.
Shunsuke Kiuchi +7 more
doaj +2 more sources
Bisoprolol in cardiovascular disease treatment
Кардиоваскулярная терапия и профилактика, 2008 Literature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac ...
S. N. Tolpygina, S. Yu. Martsevich
doaj +2 more sources
Drug Design, Development and Therapy, 2012 Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Iwan Dwi Santoso,2 Arini Setiawati,3 Liana W Susanto11Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, Equilab ...
Tjandrawinata RR +5 more
doaj +1 more source